Conversely, the effect of FAA2 was significantly inhibited only by the CB2 antagonist (AM630), as well as by the CB1 and CB2 antagonists together, showing that the FAA2 pool preferably binds to CB2, which may be explained by the fact that CB2 is expressed more than CB1 in gliomas [14]. Here, CNR1 is linked to central nervous system cancer.